Cargando…
Assessment and monitoring of biologic drug adverse events in patients with psoriasis
BACKGROUND: Current treatment guidelines for biologic therapies in psoriasis differ in their recommendation for the monitoring of adverse events. OBJECTIVE: The aim of this paper was to draw together evidence from the currently available guidelines as a summary of how biologics licensed for the trea...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683127/ https://www.ncbi.nlm.nih.gov/pubmed/29387593 http://dx.doi.org/10.2147/PTT.S68869 |